Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition

被引:9
作者
Schwedt, Todd J. [1 ]
Tassorelli, Cristina [2 ,3 ]
Silberstein, Stephen D. [4 ]
Szperka, Christina L. [5 ,6 ]
Kurth, Tobias [7 ]
Pozo-Rosich, Patricia [8 ,9 ]
Amin, Faisal Mohammad [10 ,11 ]
Lipton, Richard B. [12 ]
Dodick, David W. [1 ]
Ashina, Messoud [10 ]
Diener, Hans-Christoph [13 ]
Terwindt, Gisela M. [14 ]
机构
[1] Mayo Clin, Dept Neurol, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA
[2] Natl Neurol Inst C Mondino Fdn, Headache Sci & Neurorehabil Unit, Pavia, Italy
[3] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy
[4] Thomas Jefferson Univ, Jefferson Headache Ctr, Philadelphia, PA USA
[5] Univ Penn, Childrens Hosp Philadelphia, Div Neurol, Perelman Sch Med, Philadelphia, PA USA
[6] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA USA
[7] Charite Univ Med Berlin, Inst Publ Hlth, Berlin, Germany
[8] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Vall dHebron Res Inst, Headache Unit,Neurol Dept, Barcelona, Spain
[9] Univ Autonoma Barcelona, Headache Res Grp, Vall dHebron Res Inst, Barcelona, Spain
[10] Univ Copenhagen, Rigshosp Glostrup, Fac Hlth & Med Sci, Danish Headache Ctr,Dept Neurol, Glostrup, Denmark
[11] Univ Copenhagen, Rigshosp, Fac Hlth & Med Sci, Dept Neurorehabil Traumat Brain Injury, Copenhagen, Denmark
[12] Albert Einstein Coll Med, Dept Neurol, Dept Epidemiol & Populat Hlth, Dept Psychiat & Behav Sci, Bronx, NY USA
[13] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany
[14] Leiden Univ Med Ctr, Dept Neurol, Leiden, Netherlands
关键词
Headache; registry; patient reported outcomes; biorepository; biobank; real world evidence; database; migraine; common data elements; MIGRAINE TREATMENT; TARGET TRIAL; QUESTIONNAIRE; VALIDATION; IMPACT; INSTRUMENT; DISABILITY; DIAGNOSIS; VALIDITY; OUTCOMES;
D O I
10.1177/03331024221099035
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Clinic-based headache registries collect data for a wide variety of purposes including delineating disease characteristics, longitudinal natural disease courses, headache management approaches, quality of care, treatment safety and effectiveness, factors that predict treatment response, health care resource utilization, clinician adherence to guidelines, and cost-effectiveness. Registry data are valuable for numerous stakeholders, including individuals with headache disorders and their caregivers, healthcare providers, scientists, healthcare systems, regulatory authorities, pharmaceutical companies, employers, and policymakers. This International Headache Society document may serve as guidance for developing clinic-based headache registries. Use of registry data requires a formal research protocol that includes: 1) research aims; 2) methods for data collection, harmonization, analysis, privacy, and protection; 3) methods for human subject protection; and 4) publication and dissemination plans. Depending upon their objectives, headache registries should include validated headache-specific questionnaires, patient reported outcome measures, data elements that are used consistently across studies (i.e., "common data elements"), and medical record data. Amongst other data types, registries may be linked to healthcare and pharmacy claims data, biospecimens, and neuroimaging data. Headache diagnoses should be made according to the International Classification of Headache Disorders diagnostic criteria. The data from well-designed headache registries can provide wide-ranging and novel insights into the characteristics, burden, and treatment of headache disorders and ultimately lead to improvements in the management of patients with headache.
引用
收藏
页码:1099 / 1115
页数:17
相关论文
共 66 条
[1]   Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition [J].
Abu-Arafeh, Ishaq ;
Hershey, Andrew D. ;
Diener, Hans-Christoph ;
Tassorelli, Cristina .
CEPHALALGIA, 2019, 39 (07) :803-816
[2]   Atogepant for the Preventive Treatment of Migraine [J].
Ailani, Jessica ;
Lipton, Richard B. ;
Goadsby, Peter J. ;
Guo, Hua ;
Miceli, Rosa ;
Severt, Lawrence ;
Finnegan, Michelle ;
Trugman, Joel M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (08) :695-706
[3]   Guidelines for controlled trials of drugs in tension-type headache: Second edition [J].
Bendtsen, L. ;
Bigal, M. E. ;
Cerbo, R. ;
Diener, H. C. ;
Holroyd, K. ;
Lampl, C. ;
Mitsikostas, D. D. ;
Steiner, T. J. ;
Tfelt-Hansen, P. .
CEPHALALGIA, 2010, 30 (01) :1-16
[4]   ACC/AHA/STS Statement on the Future of Registries and the Performance Measurement Enterprise [J].
Bhatt, Deepak L. ;
Drozda, Joseph P., Jr. ;
Shahian, David M. ;
Chan, Paul S. ;
Fonarow, Gregg C. ;
Heidenreich, Paul A. ;
Jacobs, Jeffrey P. ;
Masoudi, Frederick A. ;
Peterson, Eric D. ;
Welke, Karl F. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (20) :2230-2245
[5]   A systematic review of the effect of retention methods in population-based cohort studies [J].
Booker, Cara L. ;
Harding, Seeromanie ;
Benzeval, Michaela .
BMC PUBLIC HEALTH, 2011, 11
[6]  
Buse DC, 2009, MAYO CLIN PROC, V84, P422, DOI 10.1016/S0025-6196(11)60561-2
[7]   Child Neurology Telemedicine: Understanding the Data We Have and Finding the Patients We Do Not See [J].
Chadehumbe, Madeline ;
Craig, Sansanee ;
Stephenson, Donna ;
Helbig, Ingo .
PEDIATRIC NEUROLOGY, 2021, 116 :84-84
[8]   Reliability and validity of the Migraine Therapy Assessment Questionnaire [J].
Chatterton, ML ;
Lofland, JH ;
Shechter, A ;
Curtice, WS ;
Hu, XH ;
Lenow, J ;
Smullens, SN ;
Nash, DB ;
Silberstein, SD .
HEADACHE, 2002, 42 (10) :1006-1015
[9]   Usefulness of a photophobia questionnaire in patients with migraine [J].
Choi, J-Y ;
Oh, K. ;
Kim, B-J ;
Chung, C-S ;
Koh, S-B ;
Park, K-W .
CEPHALALGIA, 2009, 29 (09) :953-959
[10]   The Development of a Survey to Measure Completeness of Response to Migraine Therapy [J].
Coon, Cheryl D. ;
Fehnel, Sheri E. ;
Davis, Kimberly H. ;
Runken, M. Chris ;
Beach, M. E. ;
Cady, Roger K. .
HEADACHE, 2012, 52 (04) :550-572